[go: up one dir, main page]

WO2008149668A1 - Protein-containing composition - Google Patents

Protein-containing composition Download PDF

Info

Publication number
WO2008149668A1
WO2008149668A1 PCT/JP2008/059304 JP2008059304W WO2008149668A1 WO 2008149668 A1 WO2008149668 A1 WO 2008149668A1 JP 2008059304 W JP2008059304 W JP 2008059304W WO 2008149668 A1 WO2008149668 A1 WO 2008149668A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
component
molecular weight
composition
containing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/059304
Other languages
French (fr)
Japanese (ja)
Inventor
Kenji Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of WO2008149668A1 publication Critical patent/WO2008149668A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

[PROBLEMS] To provide a composition which shows a high temporal stability with little denaturation of a protein having a molecular weight of from 75000 to 1000000 even after prolonged storage. [MEANS FOR SOLVING PROBLEMS] A composition containing the following components (1) and (2), wherein the content of the component (2) in the composition is from 0.75 to 10% by weight and the total amount of the component (1) is from 20 to 50 mol per mol of the component (2), is provided: (1) at least one member selected from an amino acid, a peptide and a protein having a molecular weight of from 75 to 68000; and (2) a protein having a molecular weight of from 75000 to 1000000.
PCT/JP2008/059304 2007-06-07 2008-05-21 Protein-containing composition Ceased WO2008149668A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007152170A JP5322405B2 (en) 2007-06-07 2007-06-07 Protein-containing composition
JP2007-152170 2007-06-07

Publications (1)

Publication Number Publication Date
WO2008149668A1 true WO2008149668A1 (en) 2008-12-11

Family

ID=40093493

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/059304 Ceased WO2008149668A1 (en) 2007-06-07 2008-05-21 Protein-containing composition

Country Status (2)

Country Link
JP (1) JP5322405B2 (en)
WO (1) WO2008149668A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010061490A1 (en) 2008-11-27 2010-06-03 シャープ株式会社 Liquid crystal display and method for producing the same
JP5716883B2 (en) * 2009-06-09 2015-05-13 Jsr株式会社 Manufacturing method of liquid crystal display element
JP5621966B2 (en) * 2009-09-02 2014-11-12 Jsr株式会社 Manufacturing method of liquid crystal display element
JP5884258B2 (en) * 2009-09-18 2016-03-15 Jnc株式会社 Liquid crystal aligning agent, liquid crystal aligning film, method for producing liquid crystal aligning film, and liquid crystal display element
JP2012158615A (en) * 2012-05-28 2012-08-23 Kobayashi Pharmaceutical Co Ltd Method for inhibiting protein denaturation caused by reducing sugar

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494948B1 (en) * 1970-12-26 1974-02-04
JPS6430A (en) * 1987-03-24 1989-01-05 Chugai Pharmaceut Co Ltd Gradually releasing preparation
JPH02231037A (en) * 1988-12-29 1990-09-13 American Home Prod Corp Randomized palm oil composition for infant prescription
JPH0499440A (en) * 1980-12-05 1992-03-31 Schreiber Foods Inc Condensed milk
JPH0980051A (en) * 1995-09-14 1997-03-28 Sanyo Chem Ind Ltd Solution for stabilizing solid phase immunological reagent
JPH09318628A (en) * 1996-05-31 1997-12-12 Toray Ind Inc Fixing method for immunologically active material
JP2005514017A (en) * 2001-12-21 2005-05-19 ワイス Compositions for infant formulas containing large amounts of alpha-lactalbumin
JP2006149371A (en) * 2004-08-24 2006-06-15 Asama Chemical Co Ltd Whey protein food

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822085B2 (en) * 1977-07-19 1983-05-06 株式会社ミドリ十字 Intravenous gamma globulin preparations
CA2049342A1 (en) * 1989-03-27 1990-09-28 Sally Bolmer Formulations for stabilizing of igm antibodies
JPH0565233A (en) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc Monoclonal antibody-containing lyophilized preparation
JPH04346934A (en) * 1991-05-24 1992-12-02 Green Cross Corp:The Liquid preparation of γ-globulin
JPH06508371A (en) * 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ Orally administrable therapeutic protein and its production method
WO2004060343A1 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS494948B1 (en) * 1970-12-26 1974-02-04
JPH0499440A (en) * 1980-12-05 1992-03-31 Schreiber Foods Inc Condensed milk
JPS6430A (en) * 1987-03-24 1989-01-05 Chugai Pharmaceut Co Ltd Gradually releasing preparation
JPH02231037A (en) * 1988-12-29 1990-09-13 American Home Prod Corp Randomized palm oil composition for infant prescription
JPH0980051A (en) * 1995-09-14 1997-03-28 Sanyo Chem Ind Ltd Solution for stabilizing solid phase immunological reagent
JPH09318628A (en) * 1996-05-31 1997-12-12 Toray Ind Inc Fixing method for immunologically active material
JP2005514017A (en) * 2001-12-21 2005-05-19 ワイス Compositions for infant formulas containing large amounts of alpha-lactalbumin
JP2006149371A (en) * 2004-08-24 2006-06-15 Asama Chemical Co Ltd Whey protein food

Also Published As

Publication number Publication date
JP2008303176A (en) 2008-12-18
JP5322405B2 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
WO2008089491A3 (en) Modifications of peptide compositions to increase stability and delivery efficiency
WO2006105112A3 (en) Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people
WO2008043822A3 (en) Amino acid sequences that bind to a desired molecule in a conditional manner
WO2009057775A1 (en) Anti-fatigue agent comprising amino acid composition
WO2010000801A3 (en) Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
WO2008149668A1 (en) Protein-containing composition
WO2008028977A3 (en) Serum albumin binding proteins with long half-lives
WO2010026010A3 (en) Hair treatment agent having low-dose oligopeptides
WO2007148224A3 (en) Polypeptide
WO2006001023A3 (en) Chimeric proteins and uses thereof
WO2007097903A3 (en) Hiv fusion inhibitor peptides with improved biological properties
WO2006020720A3 (en) Stable pegylated interferon formulation
WO2007030573A3 (en) Polypeptides useful for molecular weight determinations
EA200802128A1 (en) NEW NUTRITSEVTIKY COMPOSITIONS
WO2008081519A1 (en) Sweet-type seasoning compositions containing high proportion of amino acid and yeast for obtaining the same
NZ606723A (en) Glatiramer acetate molecular weight markers
WO2008105178A1 (en) Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent
MX2011012742A (en) Methylglyoxal-scavenging compounds and their use for the prevention and treatment of pain and/or hyperalgesia.
WO2005002602A3 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
CA2455776A1 (en) Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
WO2007085728A3 (en) Composition containing several botulic toxins
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2011058315A3 (en) Glucose sensor
WO2009108713A3 (en) Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
WO2008069012A3 (en) Ejection liquid and ejection method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08753031

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08753031

Country of ref document: EP

Kind code of ref document: A1